Valeant reports revenue increase, net income decrease in third quarter

Valeant Pharmaceuticals reported $2.8 billion in total revenues in the third quarter 2015, a 36% increase from the third quarter of last year, according to a press release.Net income for the third quarter was $51.7 million vs. $276.4 million in the third quarter 2014.